Treating tough tumors by exploiting their iron 'addiction' :

Researchers at the University of California, San Francisco, have successfully leveraged an FDA-approved drug to halt growth of tumors driven by mutations

Related Keywords

San Francisco , California , United States , Adam Olshen , James Korkola , Michael Evans , Honglin Jiang , Eric Collisson , Bryan Muir , Ryan Gonciarz , Iwei Yeh , Spencer Behr , Byron Hann , Adam Renslo , University Of California , Oregon Health Sciences University , Helen Diller Family Comprehensive Cancer Center , Experimental Medicine , Diller Family Comprehensive Cancer , Cancer Drug , New Drug Combinations , Ning Zhao , Yung Hua Wang , Oregon Health ,